在这场高规格赛事中，北大医疗鲁中医院团队凭借临床实践与创新方案脱颖而出，一举斩获两项荣誉：品管圈项目 《提高全院中医护理适宜技术的实施率》获三等奖，《智慧管理住院"一站式"服务模式构建及时效优化研究》获优秀 奖。这份成绩不仅是对项目的国际认可，更彰显医院在医疗质量改进领域的专业深度与创新活力。 医疗质量是医院生命线，质量改进项目是医院质量建设的关键抓手。自项目启动，团队以临床需求为导向、患者满意 为目标，精准破解工作痛点，搭建科学改进框架，反复打磨方案，确保对策贴合临床实际、具备落地价值，将"以患者 为中心"理念融入每一处细节。 近日，第十届亚洲质量功能展开与创新研讨会暨质量改进与创新案例大赛在杭州落幕。作为亚洲医疗质量领域的标杆 赛事，活动吸引各国医疗机构顶尖专家、质量管理者及临床骨干齐聚，共探医疗质量提升前沿路径。 成绩背后，是北大医疗鲁中医院长期坚守"以质量为核心，以创新为驱动"的发展理念。成绩的取得既是对过往质量改 进工作的肯定，更是未来前行的鞭策。 未来，北大医疗鲁中医院将以此为新起点，借鉴国际先进质量管理经验，聚焦临床诊疗精准化、护理服务优质化、就 医流程高效化，为患者提供安全舒心的医疗体验。(崔 ...

9月22日，广州中医药大学第一附属医院被曝发生伤医事件。《中国新闻周刊》记者从多位知情人士处获悉，事发于当日上午，伤者系该院骨科一名王姓 主任医师及跟诊的1名学生。王医生经抢救，已脱离生命危险。受伤学生伤势相对较轻。 张晓（化名）是该院的一名医生，参与了对王医生的部分抢救工作。他对《中国新闻周刊》透露，王医生身上有多处伤口，"受伤很重"，行凶者已被抓 捕。 广州中医药大学第一附属医院6楼骨科门诊。李木/摄 多位知情人士告诉《中国新闻周刊》，王医生为人友善。百度健康信息显示，王医生患友评分为5.0，累计发布1.8万条科普内容。王医生在多个社交平台 有医学科普账号，其视频号最新一条视频更新于9月21日。 据潇湘晨报报道，记者此前致电白云区卫生健康局办公室，工作人员表示，卫生健康局医政科正在处理，是否医患纠纷需联系医政科。医政科工作人员则 回应称需走程序才能接受采访。广州三元里派出所一工作人员回应称，确有伤人事件，"不便透露"是否与医患纠纷有关，"肯定会依法依规处理"。 另据红星新闻报道，22日晚11时许，该院骨科科室的一名医生告诉记者，目前王医生已经做完手术，已送到ICU病房。 每经编辑｜程鹏 王医生是22日上午 ...

Core Viewpoint - He Eye Hospital's stock price has experienced fluctuations, with a year-to-date increase of 2.14% but a significant decline in recent trading periods, indicating potential volatility in investor sentiment [2]. Company Overview - He Eye Hospital Group, established on October 15, 2009, and listed on March 22, 2022, is located in Shenyang, Liaoning Province. The company specializes in providing ophthalmic specialty diagnosis and treatment services [2]. - The revenue composition of He Eye Hospital includes: Vision services (30.24%), Refractive surgery correction services (24.16%), Non-surgical treatments (20.02%), Cataract diagnosis and treatment services (13.68%), Vitreoretinal diagnosis and treatment services (8.09%), Other ophthalmic diagnosis and treatment services (3.20%), and Other business income (0.61%) [2]. Financial Performance - As of June 30, 2025, He Eye Hospital reported a revenue of 560 million yuan, a year-on-year decrease of 4.22%. However, the net profit attributable to shareholders was 44.32 million yuan, reflecting a significant year-on-year increase of 84.19% [2]. - The company has distributed a total of 348 million yuan in dividends since its A-share listing, with 275 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for He Eye Hospital was 10,800, an increase of 15.03% from the previous period. The average circulating shares per person decreased by 13.07% to 7,684 shares [2]. - Among the top ten circulating shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B fund held 2.7947 million shares, a decrease of 1.7584 million shares compared to the previous period [3].

北中医深圳医院党委书记黄国付表示，专科楼的启用，是医院空间环境、楼层布局的进一步优化，也是 专病专科进一步拓展的体现，接下来，皮肤科、康复科和制剂室将继续发挥各自优势，提升学科发展水 平、科研能力，为患者提供更优质的服务。 据介绍，该院皮肤科与医疗美容科迁入专科楼四层后，诊疗环境与设施迎来全面升级。科室坚持中西医 结合诊疗路径，设立古中医工作室与中医经典病房，开展多项中医适宜技术，包括经络针刺、灸法、拔 罐刮痧及中药临方制剂等。科室拥有专业人员团队，提供痤疮、黄褐斑等16类皮肤专病诊疗服务。同时 配备过敏检测、皮肤生理功能评估及护肤品成分检测等多种检测体系，为患者提供更全面的诊疗支持。 康复科位于专科楼五层，作为全院平台科室，重点开展神经康复、骨伤术后康复等疾病康复。科室设置 现代康复区与传统康复区，两区物理分隔、功能互补。现代康复治疗区设有物理手法治疗区、作业治疗 训练区、运动康复训练区等十余个功能区域，配备超声波、光疗、电疗、磁疗等设备。传统康复治疗区 则提供针灸、推拿等中医特色诊疗服务。科室新增"体态矫正"与"颞下颌疾病"两个专科门诊，扩展了神 经康复、骨伤康复、疼痛康复等服务范围。 9月22日，北京中 ...

Core Viewpoint - Innovation Medical's stock has experienced significant fluctuations, with a year-to-date increase of 176.63% but a recent decline in the last five trading days by 9.68% [1] Financial Performance - As of June 30, 2023, Innovation Medical reported a revenue of 402 million yuan, a year-on-year decrease of 1.60%, while the net profit attributable to shareholders was -11.36 million yuan, an increase of 29.12% year-on-year [2] - The company has distributed a total of 55.87 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [2] Stock Market Activity - On September 22, 2023, Innovation Medical's stock price was 22.02 yuan per share, with a trading volume of 557 million yuan and a turnover rate of 5.99%, resulting in a total market capitalization of 9.717 billion yuan [1] - The stock has appeared on the "Dragon and Tiger List" 18 times this year, with the most recent appearance on September 5, 2023, showing a net buy of -121 million yuan [1] Shareholder Information - As of June 30, 2023, the number of shareholders for Innovation Medical was 82,000, an increase of 20.38% from the previous period, with an average of 5,074 circulating shares per shareholder, a decrease of 16.93% [2] Industry Classification - Innovation Medical is classified under the pharmaceutical and biological industry, specifically in the medical services sector, with concepts including ophthalmology, strong annual performance, QFII holdings, medical devices, and artificial intelligence [2]

Core Points - The establishment of the "Shanghai Huashan Hospital Orthopedic Professor Team Studio" marks a significant collaboration between Zhenjiang Traditional Chinese and Western Medicine Hospital and Shanghai Huashan Hospital [5][7] - The collaboration aims to enhance healthcare services in the Zhenjiang region by introducing advanced techniques and standardized treatment processes from Huashan Hospital [7][11] - The partnership focuses on three core areas: discipline construction, talent cultivation, and scientific research innovation, ensuring top-tier expert resources and sustainable talent development for local orthopedic patients [11] Group 1 - The unveiling ceremony was attended by key personnel from both hospitals, highlighting the importance of this collaboration [1][5] - The collaboration will involve regular expert consultations, difficult case discussions, and high-difficulty surgical demonstrations to improve local healthcare capabilities [7][9] - The orthopedic team from Shanghai Huashan Hospital is part of the "Jinshan Talent" initiative, aimed at attracting high-level talent to Zhenjiang [11]

Group 1 - The core viewpoint of the news is that Yingkang Life has shown a significant increase in stock price and trading activity, indicating positive market sentiment despite recent fluctuations [1][2] - As of September 19, Yingkang Life's stock price rose by 2.08% to 11.76 CNY per share, with a total market capitalization of 8.814 billion CNY [1] - The company has experienced a year-to-date stock price increase of 27.83%, with a recent decline of 8.55% over the last five trading days [1] Group 2 - Yingkang Life, established on August 6, 1998, and listed on December 9, 2010, is based in Qingdao, Shandong Province, and specializes in medical devices and services [2] - The company's main business segments include the development, production, and sales of medical equipment, particularly focusing on cancer treatment technologies [2] - As of September 10, the number of shareholders increased by 22.06% to 24,500, while the average circulating shares per person decreased by 18.07% to 26,191 shares [2] Group 3 - Yingkang Life reported a revenue of 843 million CNY for the first half of 2025, reflecting a year-on-year growth of 2.40%, and a net profit of 61.83 million CNY, up 12.82% year-on-year [2] - The company has distributed a total of 29.48 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]

Core Viewpoint - The National Health Commission's Hospital Management Research Institute has announced the selected project units for the construction of weight management centers in medical institutions, with Weifang Traditional Chinese Medicine Hospital being one of the selected units [1][3]. Group 1: Project Objectives - The project aims to improve the construction and management standards of weight management centers, enhance multidisciplinary collaboration, elevate the professional level of medical staff, optimize service processes, and strengthen social education and patient management [3]. - The initiative seeks to summarize effective and replicable management models for weight management centers, providing typical experiences and cases for reference, thereby promoting the professionalization and standardization of weight management services in medical institutions [3]. Group 2: Weifang Traditional Chinese Medicine Hospital's Weight Management Center - The weight management center is led by the endocrinology department and collaborates with various specialties, including clinical nutrition, acupuncture and massage, gastrointestinal surgery, rehabilitation, and psychology, to provide a comprehensive solution for patients [6]. - The center addresses issues such as simple obesity, metabolic syndrome, and postoperative weight rebound, utilizing traditional Chinese medicine's holistic approach and differential treatment principles to develop dietary plans that integrate food therapy and medication [8]. Group 3: Treatment and Monitoring Techniques - The center employs modern medical technologies, including Inbody body composition analysis, to dynamically monitor over ten indicators such as body fat rate and basal metabolic rate [12]. - The treatment approach combines traditional Chinese medicine techniques with modern medical methods, including GLP-1 receptor agonists and weight loss surgery, forming a comprehensive intervention model that addresses obesity and related metabolic diseases like diabetes and fatty liver [12].

Core Viewpoint - The launch of the "0 Yuan Benefit Card" marks the beginning of the 75th anniversary celebration of Zibo Central Hospital, highlighting its commitment to providing accessible healthcare services to the community [1][2]. Group 1: Hospital Development and Achievements - Zibo Central Hospital has evolved from a simple clinic to a provincial-level regional medical center with 3,373 open beds and over 4,000 staff members over 75 years [1]. - The hospital boasts 11 provincial clinical key specialties, 3 provincial first-batch medical and health key disciplines, and 2 provincial boutique specialty disciplines, ranking among the top in the province [1]. - The hospital recorded 1.913 million outpatient visits, approximately 70,000 surgeries, and 141,000 discharged patients annually, demonstrating its expanding quality medical resources [1]. Group 2: Community Engagement and Services - The "0 Yuan Benefit Card" initiative offers free outpatient registration fees, including over 7,000 expert outpatient slots and 2,000 general outpatient slots, as part of the hospital's anniversary celebration [2]. - The hospital has implemented 26 convenience service measures, such as "I give my parking space to patients" and "one registration covers three days," addressing common healthcare challenges faced by the public [3]. Group 3: Recognition and Quality Development - Zibo Central Hospital was recognized in the 2025 Shandong Province May Day Labor Award, affirming its achievements in high-quality development [4]. - The hospital has seen a 43% increase in delivery volume and a 32% increase in outpatient volume in its obstetrics department, attributed to an efficient emergency response mechanism [5]. Group 4: Talent Development and Research Innovation - The hospital emphasizes talent cultivation and research innovation, offering up to 4 million yuan in recruitment rewards and research startup funds [7]. - Collaborations with local enterprises focus on joint talent training and research platform construction, enhancing the transformation of medical research outcomes [7]. Group 5: Regional Impact and Future Goals - The hospital has sent 32 medical personnel to assist in medical work in Angren County, providing free surgeries for 47 Tibetan children and conducting regular visits to remote areas [8]. - A comprehensive renovation of the old outpatient building is underway, expected to enhance the hospital's infrastructure by the end of 2026 [8]. - The hospital aims to continue its "1364" work focus, enhancing its quality medical resources and expanding its capabilities in the coming years [8].

Core Viewpoint - The resignation of Chen Dongfeng, the General Manager of Lianchi Hospital Group, raises concerns about the company's future strategic planning and development amidst ongoing challenges in its listing process [7]. Group 1: Resignation of Key Executive - Chen Dongfeng has resigned from his positions as a director, member of the remuneration and assessment committee, and General Manager of Lianchi Hospital, effective immediately due to personal reasons [2]. - Chen Dongfeng's annual salary was 1.07 million yuan, significantly higher than that of the Chairman and other executives [2]. Group 2: Company Performance - Lianchi Hospital's revenue has shown steady growth, increasing from 228 million yuan in 2018 to 419 million yuan in 2024, with a 19.95% year-on-year growth in the first half of 2025, achieving 233 million yuan [4]. Group 3: Listing Attempts - The company has faced multiple setbacks in its listing journey, initially attempting to list on the New Third Board in 2015, then shifting to the Growth Enterprise Market in 2021, and later to the Beijing Stock Exchange in 2022 [5]. - As of July 2024, Lianchi Hospital announced plans to apply for listing on the Beijing Stock Exchange, intending to raise funds for the relocation of the Zibo Lianchi Orthopedic Hospital and for information technology upgrades [5]. - However, the company has not yet engaged a counseling agency or signed a counseling agreement, indicating significant uncertainty in its listing process [5][6].